MedPath

ifedipine and Nicorandil in treatment of severe pre-eclampsia

Not Applicable
Recruiting
Conditions
Pregnancy and Childbirth
Severe pre-eclampsia
Registration Number
PACTR201803003150307
Lead Sponsor
niversity of alexandria
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
140
Inclusion Criteria

1)Greater than 30 weeks of gestation.
2)Uncomplicated severe preeclampsia on the basis of :
a-severe hypertension [systolic blood pressure (SBP) ¿160 mmHg and/or diastolic blood pressure (DBP) ¿110 mmHg].
b-clinically significant proteinuria (0.3 g or more of protein in 24-h urine collection).

Exclusion Criteria

1)Imminence of eclampsia.
2)Chronic hypertension or other concomitant chronic diseases

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
control of blood pressure;changes in doppler ultrasound evaluation of the umbilical artery
Secondary Outcome Measures
NameTimeMethod
changes in Serum endothelial nitric oxide synthase, antioxidant enzyme, superoxide dismutase blood level. ¿The biomarker of oxidative stress, malondialdehyde (MDA) serum level. ¿Platelet aggregation
© Copyright 2025. All Rights Reserved by MedPath